- Towards a new era and liaison of cancer research and life science -
Cancer research in recent years has made extensive progress and the long-term survival of patients has markedly improved for various cancers. This progress has accelerated over the past decade following the completion of the Human Genome Project in 2000. On the basis of achievements in basic research, translational studies linked to clinical applications are being widely conducted. These advances give us a great sense of anticipation as we look forward to a new era of sophisticated cancer diagnosis, therapy and prophylactic methods. The Japanese Cancer Association has been actively involved in contributions to advancing and promoting such cancer research.
In the meantime, we still routinely face therapy-resistant, high-grade malignancies without significant improvements in prognosis. There is no question that further understanding of these malignancies and establishment of a new paradigm for diagnosis and treatment is required. It is also increasingly important to provide further impetus toward fundamental understanding of the most modern scientific aspects of “what cancer is biologically.” This requires close global linkage and multidisciplinary collaboration between those involved in cancer research and various other fields of life sciences. It is incumbent upon the Japanese Cancer Association to make a significant contribution towards this end.
Thus, in the 71st Annual Meeting of the Japanese Cancer Association, we have set the main theme of the meeting as “Towards a new era and liaison of cancer research and life science.” We will be very happy if this Meeting can serve as a departure point for future pivotal cancer research.
Noriyuki Sato, MD, PhD
President, 71st Annual Meeting of the Japanese Cancer Association
(Professor, Department of Pathology, Sapporo Medical University School of Medicine)